Welcome to the Cochrane Tobacco Addiction Group's website
Cochrane TAG were established in 1996 and form part of Cochrane, an international not-for-profit and independent organization, dedicated to producing and disseminating up-to-date, accurate information about the effects of healthcare worldwide. The major product of Cochrane is the Cochrane Database of Systematic Reviews which is published quarterly as part of The Cochrane Library.
Our group produce systematic reviews of the evidence on interventions to prevent and treat tobacco addiction. This includes interventions for smoking cessation, for preventing smoking uptake, and public policy interventions for reducing smoking prevalence.
We also manage a small suite of reviews on food allergy interventions, transgender health, and diagnostic test accuracy.
We are passionate about disemminating our reviews and getting quality evidence out there to the people who need it- healthcare commissioners, providers and users.
The National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Tobacco Addiction Group and provides core funding for the editorial base. We also receive project specific funding from Cancer Research UK (CRUK) and the British Heart Foundation (BHF).
You can follow us on Twitter @CochraneTAG 
Cochrane TAG is disbanding in March 2023 and is no longer accepting any new submissions or proposals for reviews. Potential authors should see the below message from Cochrane:
A new chapter for Cochrane
Cochrane has embarked on an important change programme to transform the way we produce high-quality, independent and timely evidence. The new model is designed to ensure Cochrane remains viable, sustainable, and focused on the greatest global health and care challenges now and into the future.
As part of the new model we are implementing a Central Editorial Service to streamline the editorial process. At the same time, from March 2023, Cochrane Review Groups in the UK will no longer receive NIHR funding. If you are an author currently writing a protocol, review, or update, we are working to ensure a smooth transition with minimal impact on your work.
We are very grateful to everyone who has contributed to Cochrane CTAG and very much hope that you will continue to give your time and expertise to Cochrane. We encourage you to look out for further communications about Cochrane's plans for the future and new opportunities to get involved. You can stay connected by:
• Following Cochrane on your favourite social media platform
• Opting in to Cochrane email communications in your Cochrane Account